BridgeBio raises $1 billion in convertible preferred equity

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to BridgeBio raises $1 billion in convertible preferred equity

BridgeBio Raises $1 Billion in Preferred Equity to Accelerate Present and Upcoming Launches

July 1, 2026 7:30 AM EDT

- Preferred equity investment led by Sixth Street and with participation from HealthCare Royalty, a business of KKR, with an initial conversion price of approximately $138 per share (more than 100% premium to Companys 30-day VWAP)

- The financing significantly strengthens the Companys balance sheet, enabling it to efficiently allocate capital across its highest return opportunities

- The financing comes at a pivotal moment for the Company, as Attruby® continues to grow into a multi-billion-dollar blockbuster drug, and as BridgeBio prepares for three additional potential blockbuster U.S. product launches over the next 12 months across... More